Published in Int J Clin Exp Pathol on January 01, 2015
No back seat for a progression event-K-RAS as a therapeutic target in CRC. Genes Dev (2017) 0.75
Prognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysis. BMC Cancer (2017) 0.75
Risk analysis of colorectal cancer incidence by gene expression analysis. PeerJ (2017) 0.75
Identification of molecular characteristics induced by radiotherapy in rectal cancer based on microarray data. Oncol Lett (2017) 0.75
TGFBI functions similar to periostin but is uniquely dispensable during cardiac injury. PLoS One (2017) 0.75
Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature (2003) 20.48
Gene expression profiles in normal and cancer cells. Science (1997) 9.65
Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev (2005) 4.05
cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol (1992) 2.91
Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks. Oncogene (2005) 2.35
Colorectal cancer molecular biology moves into clinical practice. Gut (2010) 2.32
Organized proteomic heterogeneity in colorectal cancer liver metastases and implications for therapies. Hepatology (2013) 2.10
Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. Genes Dev (2008) 2.00
TGF-β signalling and its role in cancer progression and metastasis. Cancer Metastasis Rev (2012) 1.67
Secreted and cell surface genes expressed in benign and malignant colorectal tumors. Cancer Res (2001) 1.64
Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin. J Biol Chem (2002) 1.53
TGFBIp/betaig-h3 protein: a versatile matrix molecule induced by TGF-beta. Int J Biochem Cell Biol (2007) 1.51
TGF-β - an excellent servant but a bad master. J Transl Med (2012) 1.41
Betaig-h3 supports keratinocyte adhesion, migration, and proliferation through alpha3beta1 integrin. Biochem Biophys Res Commun (2002) 1.38
The dimensions of the CRC problem. Best Pract Res Clin Gastroenterol (2010) 1.25
Expression of Smad proteins in human colorectal cancer. Int J Cancer (1999) 1.21
TGF-β-induced (TGFBI) protein in melanoma: a signature of high metastatic potential. J Invest Dermatol (2014) 1.13
Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors. Biochem Biophys Res Commun (2008) 1.10
Induction and expression of betaig-h3 in pancreatic cancer cells. Biochim Biophys Acta (2002) 1.08
Beta ig-h3 mediates osteoblast adhesion and inhibits differentiation. Bone (2005) 1.07
Association of genetic variation in the transforming growth factor beta-1 gene with serum levels and risk of colorectal neoplasia. Cancer Res (2008) 1.03
Expression of TGF-beta-induced matrix protein betaig-h3 is up-regulated in the diabetic rat kidney and human proximal tubular epithelial cells treated with high glucose. Kidney Int (2003) 1.00
TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel-Lindau tumor suppressor. Urology (2012) 1.00
Genetic and epigenetic traits as biomarkers in colorectal cancer. Int J Mol Sci (2011) 0.90
Cost of illness in colorectal cancer: an international review. Pharmacoeconomics (2013) 0.89
TGF-β1 signalling, connecting aberrant inflammation and colorectal tumorigenesis. Curr Pharm Des (2012) 0.88
Oncostatin M promotes mesenchymal stem cell-stimulated tumor growth through a paracrine mechanism involving periostin and TGFBI. Int J Biochem Cell Biol (2013) 0.87
Lysophosphatidic acid activates TGFBIp expression in human corneal fibroblasts through a TGF-β1-dependent pathway. Cell Signal (2012) 0.83
βig-h3 regulates store-operated Ca2+ entry and promotes the invasion of human hepatocellular carcinoma cells. Cell Biol Int (2011) 0.81
[Genetic pathways in colorectal cancer: interest for the pathologist]. Ann Pathol (2002) 0.79
Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients. Int J Clin Exp Pathol (2014) 0.75